Small Molecules

Initial research into the uses of medical cannabis suggests applications across a range of diseases, but research is needed to realize cannabis’ full medical potential.

Over the past 200 years JM has established itself as a world leader within the Pharma industry

Boosting the body's built-in cannabinoid signaling receptors

The International Cannabinoid Research Society was formed in the early 1990s – and continues to grow

Patheon's Steve Lam shares his lessons learned over three decades in bioprocessing.

What do trends in small molecule drugs mean for contract manufacturers?

Pfizer researchers share the story behind the first JAK inhibitor for rheumatoid arthritis

What are biosynthetic cannabinoids? And what do they mean for pharma?

Neil Mahapatra gives the story behind a partnership with Oxford University to develop cannabinoid medicines

How unravelling the complex chemistry of the cannabis plant can lead to new medicines